Amphastar Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2017
Total Assets: $451.1M
Liabilities Breakdown FY2017
Total Liabilities: $117.3M
Asset Breakdown
Total Assets: $451.1M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $65.6M | 14.5% |
| Accounts Receivable | $36.0M | 8.0% |
| Inventory | $63.6M | 14.1% |
| Property, Plant & Equipment | $180.5M | 40.0% |
| Goodwill | $4.5M | 1.0% |
| Intangible Assets | $11.5M | 2.5% |
| Other Assets | $89.4M | 19.8% |
Liabilities Breakdown
Total Liabilities: $117.3M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $16.6M | 14.2% |
| Long-Term Debt | $45.7M | 39.0% |
| Other Liabilities | $55.0M | 46.9% |